The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Rhesonativ 625 IU/ml, solution for injection

625 international unit(s)/millilitre Solution for injection

Octapharma (IP) SPRLPA2219/003/001

Main Information

Trade NameRhesonativ 625 IU/ml, solution for injection
Active SubstancesAnti-d immunoglobulin
Strength625 international unit(s)/millilitre
Dosage FormSolution for injection
Licence HolderOctapharma (IP) SPRL
Licence NumberPA2219/003/001

Group Information

ATC CodeJ06BB Specific immunoglobulins
J06BB01 anti-D (rh) immunoglobulin

Status

Authorised/WithdrawnAuthorised
Licence Issued28/04/2006
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back